Post by PressReleaseon Apr 06, 2023 9:06am
10 Views
Post# 35382725
New Press Release - CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM